IL6 and glioblastoma: Interestingly, when we stimulated native U251MG and U87MG cells in the regular medium with the addition of recombinant human IL-6, the additional application of solely IL-6 did not enhance the AT101 cytotoxicity on native U251MG and U87MG GBM cells upon these treatment conditions.